Capture Vascular Inc. (Capture) is a Medical Device development company that was founded in May of 2013 to pursue development and commercialization of innovative medical devices.
Capture’s platform technology, the MegaVac™ Mechanical Thrombectomy System, was uniquely designed to remove thrombus and emboli throughout the peripheral and coronary vasculature. This innovative technology offers several unique features in one simple, efficient, and effective device.
Capture Vascular Inc.’s (Capture) mission is to develop and commercialize innovative medical devices and technology.
Capture’s technology benefits patients, clinicians, and payers of the healthcare system by enabling a safer, faster, and more cost-effective modality. We believe that we offer a distinct value to patients, physicians, payers, strategic partners, and shareholders with our disruptive technology.